Amelioration of inflammatory bowel disease by Bifidobacterium animalis subsp. lactis XLTG11 in combination with mesalazine

The treatment of inflammatory bowel disease (IBD) remains challenging and significantly impacts both patients and their families. This study evaluated the role of Bifidobacterium animalis subsp. lacti XLTG11 (XLTG11) in combination with mesalazine (5-ASA) in the improvement of IBD. The results demon...

Бүрэн тодорхойлолт

Номзүйн дэлгэрэнгүй

Үндсэн зохиолчид:	Weiwei Ma, Yanan Wu, Xinyue Lin, Liping Yang, Lili Huang
Формат:	Artigo
Хэл сонгох:	Inglês
Хэвлэсэн:	Frontiers Media S.A. 2024-12-01
Цуврал:	Frontiers in Microbiology
Нөхцлүүд:	Bifidobacterium animalis subsp. lacti mesalazine IBD intestinal microorganisms SCAFs
Онлайн хандалт:	https://www.frontiersin.org/articles/10.3389/fmicb.2024.1472776/full
Шошгууд:	Шошго нэмэх Шошго байхгүй, Энэхүү баримтыг шошголох эхний хүн болох!